Elos Medtech Nomination Committee appointed ahead of Annual General Meeting 2017

In accordance with resolutions passed at the Annual General Meeting in 2016, the Elos Medtech Nomination Committee shall comprise no fewer than four and no more than six members, of whom one is to be the Chairman of the Board. The members are to be appointed by those shareholders who, at the end of the month of August, are the largest shareholders in terms of voting rights in the company, as well as by the party who addition to the aforementioned is the largest shareholder.

When appointing the Nomination Committee, the rules of the Swedish Code of Corporate Governance (the Code) are to be observed, which entail, inter alia, that no member of company management may be a member of the Nomination Committee, that Board members are not to constitute a majority of the Committee and that no more than one constituent Board member of the Committee may be dependent in relation to any of the company’s major shareholders.  

In accordance with resolutions passed at the Annual General Meeting in 2015, the following members of the Nomination Committee of Elos Medtech AB have been appointed:  

-        Thomas Öster, appointed by the Öster family  
-       Ulf Runmarker, appointed by the Runmarker family
-       Bo Nilsson, appointed by the Nilsson family
-       Bengt Belfrage, appointed by Nordea Fonder
-       Stig-Arne Blom, Chairman of the Board 

The Nomination Committee’s chairman is Bengt Belfrage, appointed by the Nomination Committee.
The Nomination Committee jointly represents approximately 67% of the voting rights for all vote-carrying shares in the company. 

The Annual General Meeting of Elos Medtech AB will be held on Wednesday, 26 April 2017  

The Nomination Committee is to submit proposals regarding the following issues for approval by the 2017 Annual General Meeting:  

-        Election of Chairman of the Meeting  
-       Number of Board Directors
-       Fees for the Board of Directors, Chairman of the Board and remuneration for committee work
-       Election of Directors of the Board and Chairman of the Board
-       Fees for the auditors
-       Election of auditors
-       Tasks and principles for the Nomination Committee 

Shareholders who wish to submit proposals to the Elos Medtech Nomination Committee, may e-mail valberedning@elosmedtech.com under the heading “to the Nomination Committee” or send a letter by post to Elos Medtech AB, Nya Stadens Torg 10, SE-531 31 Lidköping, marked “to the Nomination Committee”, no later than 13 January 2017.  

Lidköping, 6 October 2016  

Elos Medtech AB (publ)  

For further information, please contact: Bengt Belfrage, Chairman of the Nomination Committee, telephone +46 (0)705 16 32 45, E-mail  bengt@belfrage.se

This is information that is such information that Elos Medtech AB (publ) is obliged to published in accordansce with the EU Market Abuse Regulation and the Securities Market Act. The information was issued for publication by the contact person stated above, on 6 October 2016, at 08:00 (CET).

For additional information about the Elos Medtech Group, visit  www.elosmedtech.com  


About Us

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental Implant Systems, Diagnostics, Medical Devices and Trauma & Spine. The Group’s net sale is approximately SEK 550 M and has about 520 employees. The Group is since 1989 traded on NASDAQ OMX Stockholm AB. The shares are classified as a Health Care company on the Small Cap list.